NewsSource: EClinCloud Official Website Archive

Good News: EClinCloud Receives the Biomedicine "Rising Star" Season 1 Nominee Award

2 min readEClinCloud Editorial Team
Archived article cover: Good news! EClinCloud wins a Biopharma "Rising Star" Season 1 Nomination Award

On 9/7, the Biomedicine "Rising Star" Season 1 awards ceremony was held in Shanghai. Liu Ping, Deputy Director of the Municipal Commission of Economy and Informatization, attended and presented awards to the winning companies. Relying on its independently developed integrated clinical evidence support SaaS cloud platform, EClinCloud—the only clinical digital services company among all award recipients—received the Biomedicine "Rising Star" Nominee Award.

 

一临云2022生物医药明日之星提名奖证书

 

Guided by the Shanghai Municipal Leading Group for Biomedical Industry Development and co-hosted by the Municipal Biomedical Industry Promotion Center and Shanghai Zhangjiang (Group) Co., Ltd., the Biomedicine "Rising Star" initiative aims to identify rising stars in biomedicine with technological breakthroughs, industry leadership, and substantial market potential through a clearly themed launch, targeted selection, scientific and professional evaluation, and integrated resource support, and to establish the initiative as a flagship branded selection event for emerging, technology-driven innovative enterprises in China's and the global biomedical field.

 

首季生物医药明日之星获奖企业名单

Image source: Shanghai Municipal Commission of Economy and Informatization

 

This event reviewed the first season of the Biopharma "Rising Star" program and presented plaques to the companies that received the Winner Award and Nominee Award. The first season was launched in 10/2021 at the opening ceremony of Shanghai International Biopharma Industry Week, and in 1/2022 the selection took place, choosing 5 companies for the Winner Award and 10 for the Nominee Award, covering frontier biopharmaceutical fields such as innovative drugs, innovative medical devices and services, and cell and gene therapy.

 

生物医药明日之星活动颁奖合影

EClinCloud Business Manager Wu Xinyu (second from left) accepting the award on behalf of the company

 

Dr. Qin Long, CEO of EClinCloud, expressed gratitude to all parties involved in the event for their encouragement and support, said he was honored to be selected for Biopharma "Rising Star," and stated that EClinCloud will rely on its integrated clinical evidence support SaaS cloud platform to deepen its focus on digital clinical trial solutions, uphold its mission of "bringing effective treatments to patients through technological innovation," and help domestic and international pharmaceutical companies and research institutions improve R&D efficiency and accelerate the market launch of drugs/devices, benefiting countless patients.

 

About EClinCloud

EClinCloud is a healthcare and life sciences technology company based in China and serving globally. Guided by its mission of "bringing effective treatments to patients through technological innovation" and driven by science and medicine, it combines digital technology with life data to build an end-to-end digital clinical trial cloud platform and provide technical solutions for clinical endpoint assessment, helping domestic and international pharmaceutical companies and research institutions improve R&D efficiency and accelerate the market launch of drugs/devices, benefiting countless patients.